Search Results for: hepatitis c

October 6, 2016October 6, 2016

FDA Warns Risk of Hepatitis B Reactivating with Certain Antiviral Drugs for Hepatitis C

Earlier this week, the U.S. Food and Drug Administration (FDA) warned about serious risks for patients infected with the hepatitis B virus (HBV) and who are being treated with certain direct-acting antiviral ... Read more

October 4, 2016October 4, 2016

Distrust and Stigmas Keep Australians with Hepatitis C from Seeking Treatment, Surveys Find

Hepatitis B, Hepatitis C, News

Patients with hepatitis C might be hesitant to seek life-saving treatment due to generalized feelings of mistrust toward the health system, and ongoing stigma from health workers toward injectable drug users, according to new research from the ... Read more

September 27, 2016October 4, 2016

NICE Approves Epclusa to Treat More Genotypes of Hepatitis C

Hepatitis C, News

The U.K. National Health Service’s (NHS) National Institute for Health and Care Excellence (NICE) recently published a new draft guidance recommending Epclusa (sofosbuvir-velpatasvir), an anti-viral drug that offers patients with chronic ... Read more

September 8, 2016September 8, 2016

Drug Users Should Have Access to New Hepatitis C Therapies or Disease Won’t Be Eradicated, Experts Say

Hepatitis C, News

Experts gathered at the 5th International Symposium on Hepatitis Care in Substance Users in Oslo, Norway, this week are discussing whether restrictions preventing substance users from accessing new hepatitis C drugs ... Read more

July 5, 2016July 5, 2016

MassHealth Expands Access to Hepatitis C Therapies Like Harvoni

Hepatitis C, News

Leaders in Massachusetts recently took steps to ensure that all members of MassHealth, the state’s health insurance program for low- and moderate-income residents, have access to medications to treat hepatitis C. Following months of negotiations, MassHealth ... Read more

June 30, 2016June 30, 2016

Epclusa for All Genotypes of Hepatitis C Virus Approved by FDA

Hepatitis C, News

The U.S. Food and Drug Administration (FDA) approved Epclusa for the treatment of patients with chronic hepatitis C virus (HCV) infection. Epclusa can be used as a monotherapy for patients without cirrhosis (late ... Read more

June 23, 2016June 23, 2016

New Hepatitis C Virus Study to Assess Host-Targeted Antiviral Drug Approach

Hepatitis C, News

Enanta Pharmaceuticals has begun dosing chronic hepatitis C virus (HCV) patients with its investigational drug EDP-494 as part of a proof-of-concept study designed to demonstrate the medicine’s efficacy in a subset of patients with ... Read more

June 16, 2016June 16, 2016

Highly Effective Interferon-Free Therapies for Hepatitis C Shown to Diminish Portal Vein Hypertension in Austrian Study

Hepatitis C, News

New interferon-free treatments for patients with hepatitis C were shown to decrease hypertension of the portal vein — which carries blood from the gut to the liver — decreasing the risk of ... Read more

June 7, 2016June 7, 2016

Economic Study Appeals for Lower Prices in New Hepatitis C Medicines

Hepatitis C, News

A recent economic study analyzed the high prices of new hepatitis C virus (HCV) medicines, prompting a wide debate about fairness and affordability. The study systematically compared prices of sofosbuvir ... Read more

May 19, 2016May 19, 2016

Treatment with New Hepatitis C Drugs Could Generate Billions in Savings Over 20 Years

Hepatitis C, News

New hepatitis C drugs cure the disease in a vast majority of patients, but the heavy price tag discourages their use. The debate on whether or not we can afford ... Read more